[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Innovent_2011 "2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2-bias Bispecific Antibody Fusion Protein) from the Phase X PoC Clinical Study in Advanced Non-small Cell Lung Cancer"
@Innovent_2011 on X 2025-06-04 01:36:03 UTC XXX followers, XXX engagements

"Nature Medicine Published Phase X Results of Innovent Biologics' Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma"
@Innovent_2011 on X 2025-07-22 12:01:28 UTC XXX followers, XX engagements

"Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms"
@Innovent_2011 on X 2025-07-01 02:19:30 UTC XXX followers, XX engagements